News & Insights

Mamotest secures $3.3 million for breast cancer screening in Latin America

The company raised $3.3 million in pre-Series A funding from Johnson & Johnson Impact Ventures, Merck, Sonen Capital and venture capital firm Sky High.
national-cancer-institute-ofWV2r94qCc-unsplash.jpg national-cancer-institute-ofWV2r94qCc-unsplash.jpg

Breast cancer survival rates are significantly lower in many emerging markets than in high-income countries. Startup Mamotest want to improve early detection in the region.

Mamotest uses AI-based diagnostics to interpret mammogram results and telehealth services to deliver results to patients. The company says it has screened 650,000 women since launching its digital health system last year; 87% of cancer-positive patients were diagnosed early enough for treatment.

READ THE COMPLETE ARTICLE ON IMPACTALPHA